Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Apex Biotechnology Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Apex Biotechnology Corp (1733-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 May 2016 Thomson Reuters Stock Report 11 $25.00

ApexBio (1733 TT):Positive Prospect with Impressive Profit

The global blood glucose monitoring (BGM) devices market has experienced a major change. Price drop of blood glucose product...

12 May 2016 MasterLink Securities Corporation 5 $46.00

五鼎 (1733):營運展望看佳,獲利表現搶眼

營運展望佳,毛利率大幅提升,獲利搶眼,給予買進評等:全球血糖檢測市場近年發生變化,美國血糖檢測產品價格調降,也衝擊到美國以外的市場,Bayer賣出血糖檢測部門,接手公司在營運尚需整合下,預料各地區廠商將積極拉貨搶市,也可望帶動國內血糖檢測廠商營收成長...

08 May 2016 MasterLink Securities Corporation 4 $23.00

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is ...

04 May 2016 GlobalData 37 $300.00

Thomson Reuters Stock Report - Apex Biotechnology Corp (1733-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Apex Biotechnology Corporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Apr 2016 Wright Reports 56 $75.00

Is Now the Time to Buy Apex Biotechnology Corp.?

09 Mar 2016 Sadif Analytics Prime 12 $25.00

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is ...

03 Mar 2016 GlobalData 37 $300.00

五鼎(1733.TT)營運回穩惟評價合理,維持中立

營運回穩,惟評價合理,建議中立:雖五鼎2016年營收在主要客戶訂單guidance多呈正面下,將穩健回升,惟考量目前本益比14倍,較過往業績成長動能較趨緩時,本益比區間多落於12-15倍來看,股價上漲空間較小,故維持中立建議。

29 Jan 2016 SinoPac Sec Inv Service 4 $23.00